Clinical Trial Update: Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer

View source ↗

Summary

This clinical trial evaluates whether genetic polymorphisms can predict response to hormonal therapy in prostate cancer. The study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Prostate Cancer | Status: UNKNOWN